Join
Live feed
·
INSIDERFilingvia Quantisnow
Rubius Therapeutics Inc. logo

SEC Form 4: Llc Partner General Iv Fund Ventures Flagship bought $6,090,000 worth of Common Stock (210,000 units at $29.00)

ByQuantisnow·Wall Street's wire, on your screen.
RUBY· Rubius Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RUBY (Rubius Therapeutics Inc.) and more on Quantisnow.